Inhibition of Protein Kinase C–β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy
Kim A. Connelly(St. Michael's Hospital), Richard E. Gilbert(St. Michael's Hospital), David Prior(St Vincent's Hospital Melbourne), Darren J. Kelly(ETH Zurich), Alison J. Cox(St. Michael's Hospital), Henry Krum(Australian Regenerative Medicine Institute), Yuan Zhang(St. Michael's Hospital), Kerri Thai(St. Michael's Hospital), Andrew Advani(St. Michael's Hospital)
Cited by 116
Related Papers
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
|The Lancet|2010|2.2k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
|The Lancet|2009|2.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
|Circulation|2004|1.2k
Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE
|European Journal of Heart Failure|2012|1.1k